menu ☰
menu ˟

Givosiran reduces neurotoxic intermediates in acute hepatic porphyria

17 Apr 2018
PARIS — Givosiran, an investigational RNA interference therapeutic, was generally well-tolerated and reduced aminolevulinic acid and porphobilinogen accumulation in patients with acute hepatic porphyria and ameliorate disease manifestations, accord...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.